久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

中文USEUROPEAFRICAASIA
China-Europe Relations

Medical care with a cutting edge

By Cecily Liu ( China Daily Europe ) Updated: 2015-01-16 10:23:13

Swiss companies helping supply china with healthcare as sharp as the famous army pocket knife

Great demand in China's medical sector has created extensive business opportunities for Switzerland's medical industry, renowned as one of the world's best.

Swiss pharmaceutical companies Novartis and Roche and other medical firms are long established in China, as is the reinsurance company Swiss Re, which plays a significant role in spreading risk in China's medical insurance market.

Also, Switzerland's availability of reputable and professional hospitals has made it a great destination for medical tourism, which is increasingly popular among Chinese travelers.

"There are still huge unmet needs in healthcare in China," says Jia Xu, China consulting partner of PricewaterhouseCoopers, who is based in Beijing. "China will remain among the world's most attractive markets in the next few years."

IMS Health says China is positioned to become the second-largest pharmaceutical market after the United States this year. By growing an estimated 15 to 18 percent a year, it is expected the market will be worth between $155 billion and $165 billion.

Swiss healthcare firms have apparent advantages in high-end targeted customers for both pharmaceuticals and vaccines, Jia says. They have operated in China for decades, with strong brands and innovative products.

Novartis, which started to do business in China in 1987, has grown from a few dozen associates to a major company hub that employs about 8,000 people.

In addition, Novartis has made significant investments in increasing research and development in China, including developing a state-of-the-art facility in Shanghai, the Novartis Institutes of BioMedical Research.

"Given this legacy of investment in China, Novartis sees a promising future in China based on ample opportunities for growth and innovation in that market," says Eric Althoff, a spokesman for Novartis.

Novartis staff at the institutes are focusing on research for gastric cancer and hepatoma, or tumors of the livers, which are indigenous to the Chinese population. Another focus is lung cancer, which affects 18.74 percent of Chinese. The institutes have also created a cancer model platform, which is useful for discovering biological markers and profiling preclinical drug candidates in Novartis' oncology pipeline.

The company is also researching treatments for diseases linked with aging, which are increasingly afflicting the Chinese population. An example is using the principles of stem cell research to explore regenerative medicine in areas such as hearing loss, obesity and sarcopenia, a degenerative loss of skeletal muscle mass.

In addition to the investment in the institutes, Novartis is collaborating with Chinese universities and hospitals on research and drug discovery. One example is the Novartis-Fudan Joint Research Laboratory, which the company formed with Fudan University to develop disease models and look for novel drug targets by using innovative molecular genetic techniques.

Althoff says Novartis sees great future growth in China, and has aligned its growth strategy with the Chinese government's priorities of improving healthcare throughout the country.

To achieve this, Novartis has engaged in numerous partnerships with public and private organizations in China, including working with several groups in the Chinese government.

Novartis has invested in programs that help to increase health awareness. In 2010 it developed Jian Kang Kuai Che, which means Health Express, in Xinjiang. It is a program that offers hygiene and health information to students, healthcare professionals and patients to promote a healthy lifestyle and help prevent common diseases.

Through JKKC, health education has reached children more than 1.4 million times and adults 60,000 times throughout more than 270 participating schools. As well, more than 1,100 doctors, nurses and medical workers have been trained in infectious diseases either in person or remotely.

Swiss Re is another important player in China's healthcare sector, working to help spread financial risks in the sector. It also uses its knowledge and expertise to help its Chinese customers, which are insurance companies, to devise the best insurance policies.

Thierry Leger, head of life and health products at Swiss Re, says that almost all of China's life and health insurance companies are its customers. For example, Swiss Re has worked with New China Life on the first cancer insurance product in China.

NCL says it has sold more than 750,000 cancer policies, which means that for just this single customer and this single product, Swiss Re is supporting healthcare protection for about that number of people in China.

Swiss Re's overall reinsurance business began supporting clients in China in 1931, and it has been providing training for healthcare insurance companies since the 1990s, when China introduced private health insurance.

Leger says that Swiss Re's work in China will help the industry better manage insurance risks in four areas: education and awareness, innovation, availability and risk management.

With risk management, Swiss Re is identifying and mitigating risks for its customers in all steps of its client value chain, from product design to pricing, risk selection and underwriting, claims management to experience monitoring and capital management, Leger says.

In 2007 Swiss Re produced a report on China's healthcare insurance challenge. It proposed a public-private partnership model for China's healthcare market in which commercial insurers could focus not only on developing the voluntary market but also help the government administer its social insurance programs.

The study was conducted in response to an invitation by the China Insurance Regulatory Commission, as an independent review to produce recommendations for the country's healthcare system. Leger says he is pleased to see the government is beginning to buy medical insurance and services from the private sector.

"During the past 10 years, private healthcare insurance has also grown rapidly. This is not by chance - it is definitely the natural outcome of economic development and has been triggered by the development of social health insurance."

He says unique advantages that Swiss Re has in the Chinese market, including its global expertise combined with local teams, bring to China research and development expertise, product innovation and design, risk management expertise, value-added service for the end consumer, a strong balance sheet and a willingness and commitment to grow together with customers.

"Perhaps most importantly, Swiss Re is aware of the social function played by insurance. With insurance in place, individuals have a level of financial security when the unforeseen happens. This helps secure the wealth that people have acquired, relieves the strain on governments and ultimately supports further economic growth."

Swiss Re sees great growth opportunities in China's healthcare reinsurance market, Leger says. The company has projected that the health protection gap, which is the shortfall in the insurance needed to cover the population, in the Asia-Pacific region could reach $197 billion in 2020, compared with $9 billion in 2011.

"This means that there is a huge shortfall in insurance," Leger says. "Swiss Re is focused on how to address that change in a sustainable way."

Another key development in Swiss-China healthcare collaboration is that of medical tourism.

Andrej Reljic, managing director of Swiss Health, Switzerland's national marketing organization for healthcare and medical services, says the country has more than 250 years of history treating patients from abroad, and its advantages include high-quality medicine, good service, medical education and experience.

Medical tourism treatments popular among Chinese visitors include check-ups, esthetic surgery, laser treatment, anti-aging programs, medical and esthetic dermatology, plastic and reconstructive surgery, dentistry and implants, he says.

Many of these treatments can be as short as one or two days, which allows patients to benefit from the stay to combine it with excursions, shopping, and other activities, says Reljic.

Jia says that healthcare sector opportunities for foreign players in China are expected to grow because China is encouraging foreign pharmaceutical and medical technology companies to enter the country, especially in areas such as trading, manufacturing and research and development.

"Additionally, China is deepening healthcare reform to encourage overseas private hospitals and nursing home investments," Jia says.

However, competition is fierce, and it is important for foreign entrants to find the right product portfolio for the China market.

Another challenge is how they can expand their businesses to broad, grassroots areas in China, given that the increase in sales and market share in developed regions has become limited, Jia says.

"With tightened regulations and increased operational costs, multinational corporations need to think out new business models to develop their business in a more efficient way while staying compliant. Moreover, more healthcare service sectors from Switzerland should consider getting into the Chinese market because the huge aging population has created a great opportunity."

cecily.liu@chinadaily.com.cn

Medical care with a cutting edge

 Medical care with a cutting edge

Andrej Reljic, managing director of Swiss Health, Switzerland's national marketing organization for healthcare and medical services

 Medical care with a cutting edge

A nurse checks a baby in Switzerland. China's medical sector has created extensive business opportunities for the country's medical industry. Photos Provided to China Daily

(China Daily European Weekly 01/16/2015 page9)

Related Stories
...
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    91精品欧美久久久久久动漫| 精品少妇一区二区三区日产乱码| 中文字幕一区二区日韩精品绯色| 最新不卡av在线| 91精品国产福利| 久久精品国产久精国产爱| 日韩亚洲欧美在线| 成人av片在线观看| 捆绑调教一区二区三区| 亚洲欧洲一区二区在线播放| 亚洲女与黑人做爰| 狠狠色综合播放一区二区| 中文天堂在线一区| 欧美一级精品大片| 欧美这里有精品| 欧美午夜电影在线播放| 九色porny丨国产精品| 国产精品乱码一区二区三区软件| 在线一区二区视频| 欧美美女直播网站| 日本aⅴ亚洲精品中文乱码| 久久你懂得1024| 欧美一级高清片| 亚洲欧美国产三级| 99re6这里只有精品视频在线观看| 亚洲欧美国产三级| 欧美成人高清电影在线| 99久久亚洲一区二区三区青草| 亚洲图片欧美一区| 国产色爱av资源综合区| 欧美最猛性xxxxx直播| 国模无码大尺度一区二区三区| 中文字幕在线不卡视频| 在线播放国产精品二区一二区四区 | 粉嫩高潮美女一区二区三区| 日韩二区在线观看| 一区二区三区四区av| 成人av电影免费在线播放| 激情综合色丁香一区二区| 亚洲成人手机在线| 一级中文字幕一区二区| 亚洲欧美日本在线| 亚洲综合999| 蜜桃久久久久久| 日本丰满少妇一区二区三区| 91久久国产综合久久| 玖玖九九国产精品| 99re亚洲国产精品| 国产东北露脸精品视频| 91蝌蚪porny九色| 91黄色免费网站| 91国偷自产一区二区三区观看 | 麻豆91在线播放免费| 日精品一区二区| 久久亚洲私人国产精品va媚药| 国产日产欧产精品推荐色| 国产日韩欧美电影| 欧美一二三区精品| 91精品在线观看入口| 在线观看亚洲成人| 午夜欧美2019年伦理| 五月天激情综合| 亚洲影视在线观看| 欧美精品一区二区久久久| 国产亚洲欧洲997久久综合| 国产欧美日本一区二区三区| 精品三级在线看| 91精品久久久久久久久99蜜臂| 欧美一卡二卡三卡四卡| 欧美色综合天天久久综合精品| 色综合久久综合网| 91浏览器在线视频| 26uuu久久天堂性欧美| 欧美一区二区二区| 国产精品久久久久久妇女6080| 日韩中文字幕不卡| 欧美日韩亚洲综合在线 欧美亚洲特黄一级 | 日本黄色一区二区| av中文字幕亚洲| 另类人妖一区二区av| 午夜a成v人精品| 亚洲国产裸拍裸体视频在线观看乱了| 国产日韩精品一区二区浪潮av| 91麻豆精品国产综合久久久久久| 一本一本大道香蕉久在线精品 | 亚洲国产精品自拍| 亚洲欧美日韩在线| 欧美系列日韩一区| 欧美肥妇bbw| 国产综合色产在线精品| 精品亚洲免费视频| 免费观看在线色综合| 免费观看在线综合| 蜜桃91丨九色丨蝌蚪91桃色| 日本网站在线观看一区二区三区| 天涯成人国产亚洲精品一区av| 亚洲一区二区三区影院| 亚洲综合免费观看高清在线观看| 亚洲人成亚洲人成在线观看图片| 中文字幕一区av| 亚洲男人的天堂网| 亚洲综合成人在线| 亚洲va欧美va人人爽| 五月天视频一区| 男女男精品视频网| 精品夜夜嗨av一区二区三区| 国产精品911| 处破女av一区二区| 成人精品国产一区二区4080| av高清久久久| 在线视频欧美精品| 欧美美女一区二区三区| 日韩欧美高清一区| 精品sm在线观看| 中文字幕欧美激情一区| 亚洲人成在线观看一区二区| 亚洲一区在线观看网站| 亚洲不卡一区二区三区| 日本美女一区二区| 国产在线视频不卡二| 成人综合婷婷国产精品久久蜜臀| 91视频观看视频| 欧美高清你懂得| 26uuu国产电影一区二区| 欧美国产97人人爽人人喊| 国产精品传媒入口麻豆| 亚洲亚洲精品在线观看| 麻豆精品国产传媒mv男同 | 大胆亚洲人体视频| 一本一道综合狠狠老| 欧美精品电影在线播放| 精品国产a毛片| 亚洲欧洲www| 日韩电影在线一区| 国产在线乱码一区二区三区| 99久久精品费精品国产一区二区| 欧美日韩国产综合久久| 精品国产伦一区二区三区观看方式 | 91年精品国产| 91麻豆精品91久久久久久清纯 | 国产精品中文有码| 91蝌蚪国产九色| 日韩一区二区三区观看| 国产丝袜在线精品| 中文字幕在线不卡国产视频| 亚洲成人久久影院| 国产一区二区三区精品欧美日韩一区二区三区| 成人动漫中文字幕| 欧美亚洲动漫制服丝袜| 91视视频在线直接观看在线看网页在线看| 在线不卡中文字幕播放| 日本一区免费视频| 亚洲国产成人av| 国产白丝网站精品污在线入口| 91激情五月电影| 久久久久久一级片| 亚洲国产一区二区在线播放| 国产做a爰片久久毛片| 在线欧美日韩精品| www久久精品| 亚洲成人在线网站| 高清av一区二区| 7777精品伊人久久久大香线蕉的| 国产日韩精品一区二区三区 | 精品一二三四区| 欧美在线观看视频一区二区三区| 久久先锋影音av鲁色资源网| 亚洲综合在线电影| 国产福利不卡视频| 91精品国产综合久久婷婷香蕉 | 亚洲色图在线看| 精品一区二区在线播放| 欧洲av一区二区嗯嗯嗯啊| 国产亚洲欧美在线| 奇米888四色在线精品| 91免费版在线看| 国产亚洲综合在线| 人人狠狠综合久久亚洲| 91理论电影在线观看| 国产亚洲欧美在线| 日本午夜一区二区| 欧洲精品中文字幕| 国产精品久久久久影院亚瑟 | 亚洲国产岛国毛片在线| 蜜乳av一区二区| 欧美亚洲一区三区| 国产精品国产三级国产有无不卡| 蜜臀精品久久久久久蜜臀| 欧美性欧美巨大黑白大战| 国产精品久久久久三级| 国产一区在线视频| 欧美一二三区在线观看| 亚洲国产成人av好男人在线观看| 9色porny自拍视频一区二区| 久久先锋影音av| 久久精品国产99国产| 欧美精品国产精品| 亚洲午夜日本在线观看| 99re视频精品| 18成人在线观看|